Italian researchers demonstrated recently that patients with inflammatory bowel disease (IBD) carrying the PNPLA3 "M" allele are at increased risk of developing hepatic steatosis and increased liver enzymes [11]. This evidence concerns the gene PNPLA3 and inflammatory bowel disease.